Skip to main content

Advertisement

Table 2 Clinical and sociodemographic characteristics at treatment initiation for participants retained within the cohort and participants lost to follow-up (n = 9997)

From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada

Characteristic Total (n) Not lost to follow-up (%) Lost to follow-up (%) P-value
All Participants 9997 8865 (88.7) 1132 (11.3)  
Sex     0.044
Female 1831 1599 (87.3) 232 (12.7)  
Male 8166 7266 (89.0) 900 (11.0)  
History of IDUa     <0.001
Yes 2141 1964 (91.7) 177 (8.3)  
No 5702 5051 (88.6) 651 (11.4)  
Aboriginal ancestryb     0.001
Yes 467 437 (93.6) 30 (6.4)  
No 4275 3788 (88.6) 487 (11.4)  
CD4 cell count (cells/μL)     0.002
<350 7689 6777 (88.1) 912 (11.9)  
≥350 2308 2088 (90.5) 220 (9.5)  
  1. IDU injection drug use
  2. an = 7843
  3. bn = 4742